Logo image of BYAH

PARK HA BIOLOGICAL TECHNOLOG (BYAH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BYAH - KYG6925R1020 - Common Stock

0.163 USD
+0.01 (+4.82%)
Last: 1/23/2026, 8:00:02 PM
0.165 USD
+0 (+1.23%)
After Hours: 1/23/2026, 8:00:02 PM
Fundamental Rating

3

BYAH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. While BYAH has a great health rating, there are worries on its profitability. BYAH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • BYAH had negative earnings in the past year.
  • In the past year BYAH had a positive cash flow from operations.
BYAH Yearly Net Income VS EBIT VS OCF VS FCFBYAH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M

1.2 Ratios

  • BYAH's Return On Assets of -331.89% is on the low side compared to the rest of the industry. BYAH is outperformed by 96.69% of its industry peers.
  • BYAH's Return On Equity of -455.43% is on the low side compared to the rest of the industry. BYAH is outperformed by 79.34% of its industry peers.
Industry RankSector Rank
ROA -331.89%
ROE -455.43%
ROIC N/A
ROA(3y)20.25%
ROA(5y)N/A
ROE(3y)81.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BYAH Yearly ROA, ROE, ROICBYAH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • BYAH has a better Gross Margin (92.99%) than 98.35% of its industry peers.
  • The Profit Margin and Operating Margin are not available for BYAH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BYAH Yearly Profit, Operating, Gross MarginsBYAH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

  • BYAH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BYAH has been reduced compared to 1 year ago.
  • BYAH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BYAH Yearly Shares OutstandingBYAH Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
BYAH Yearly Total Debt VS Total AssetsBYAH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • BYAH has an Altman-Z score of 0.02. This is a bad value and indicates that BYAH is not financially healthy and even has some risk of bankruptcy.
  • BYAH has a Altman-Z score of 0.02. This is in the lower half of the industry: BYAH underperforms 78.51% of its industry peers.
  • There is no outstanding debt for BYAH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.02
ROIC/WACCN/A
WACC8.41%
BYAH Yearly LT Debt VS Equity VS FCFBYAH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M

2.3 Liquidity

  • BYAH has a Current Ratio of 3.68. This indicates that BYAH is financially healthy and has no problem in meeting its short term obligations.
  • BYAH's Current ratio of 3.68 is amongst the best of the industry. BYAH outperforms 91.74% of its industry peers.
  • A Quick Ratio of 3.63 indicates that BYAH has no problem at all paying its short term obligations.
  • BYAH's Quick ratio of 3.63 is amongst the best of the industry. BYAH outperforms 96.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.68
Quick Ratio 3.63
BYAH Yearly Current Assets VS Current LiabilitesBYAH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

  • BYAH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2189.24%.
  • Looking at the last year, BYAH shows a quite strong growth in Revenue. The Revenue has grown by 9.33% in the last year.
EPS 1Y (TTM)-2189.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38931.58%
Revenue 1Y (TTM)9.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.29%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BYAH Yearly Revenue VS EstimatesBYAH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BYAH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYAH Price Earnings VS Forward Price EarningsBYAH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BYAH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 35.37
EV/EBITDA N/A
BYAH Per share dataBYAH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for BYAH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PARK HA BIOLOGICAL TECHNOLOG / BYAH FAQ

Can you provide the ChartMill fundamental rating for PARK HA BIOLOGICAL TECHNOLOG?

ChartMill assigns a fundamental rating of 3 / 10 to BYAH.


Can you provide the valuation status for PARK HA BIOLOGICAL TECHNOLOG?

ChartMill assigns a valuation rating of 1 / 10 to PARK HA BIOLOGICAL TECHNOLOG (BYAH). This can be considered as Overvalued.


Can you provide the profitability details for PARK HA BIOLOGICAL TECHNOLOG?

PARK HA BIOLOGICAL TECHNOLOG (BYAH) has a profitability rating of 1 / 10.